Ferring International Pharmascience Center US
Pharmaceutical & medical device company payment data from CMS Open Payments.
Total Payments
$45.0M
Doctors Paid
127
Transactions
3,734
2024 Total
$116,583
Payment Breakdown by Category
Research$44.1M (97.9%)
Consulting$856,063 (1.9%)
Travel$56,063 (0.1%)
Food & Beverage$10,651 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $44.1M | 3,143 | 97.9% |
| Consulting Fee | $856,063 | 78 | 1.9% |
| Travel and Lodging | $56,063 | 201 | 0.1% |
| Food and Beverage | $10,651 | 261 | 0.0% |
| Education | $599.53 | 51 | 0.0% |
Payments by Type
Research
$44.1M
3,143 transactions
General
$923,376
591 transactions
Research Studies & Clinical Trials
| Study Name | Total Paid | Doctors | Records |
|---|---|---|---|
| A Randomized, Double-blind, Placebo-controlled, Parallel Groups, Multicenter Trial Investigating the Efficacy and Safety of FE 999049 in Controlled Ovarian Stimulation in Women Aged 18-34 Years Undergoing Assisted Reproductive Technology | $10.2M | 0 | 409 |
| A Randomized, Double-blind, Placebo-controlled, Parallel Groups, Multicenter Trial Investigating the Efficacy and Safety of FE 999049 in Controlled Ovarian Stimulation in Women Aged 35-42 Years Undergoing Assisted Reproductive Technology | $10.0M | 0 | 370 |
| A Randomized, Double-blind Double-dummy Trial Comparing MENOPUR Solution for Injection in a Pre-filled Pen and MENOPUR Powder and Solvent for Solution for Injection (Menotropins for Injection) in a GnRH Agonist Cycle in Women Aged 18-42 Years Undergoing an Assisted Reproductive Technology Program | $7.8M | 0 | 505 |
| A Randomized, Assessor-Blinded, Multi-Center Study Investigating the Efficacy, Safety, and Tolerability of Sodium Picosulfate, Magnesium Oxide and Anhydrous Citric Acid Oral Solution versus Sodium Picosulfate, Magnesium Oxide and Anhydrous Citric Acid Powder for Oral Solution PREPOPIK for Colon Cleansing in Preparation for Colonoscopy | $4.8M | 0 | 121 |
| A Prospective, Multi-Center, Non-Comparative Trial of the Clinical Safety of the Progesterone Vaginal Ring in Women Undergoing Assisted Reproductive Technology ART Procedures | $2.8M | 0 | 195 |
| A Randomised, Double-blind, Placebo-controlled, Response-adaptive Dose-finding Trial Investigating the Efficacy, Safety and Tolerability of Oral Doses of FE 201836, With Desmopressin Orally Disintegrating Tablet as a Benchmark, During 12 Weeks of Treatment for Nocturia Due to Nocturnal Polyuria in Adults | $2.1M | 0 | 311 |
| A Randomized, Assessor-blind Trial Comparing MENOPUR Menotropins for Injection and Recombinant FSH Follicle Stimulating Hormone in a GnRH Antagonist Cycle With Single-Blastocyst Transfer in a High Responder Subject Population | $1.3M | 0 | 117 |
| A Multi-Center, Randomized, Assessor-Blind, Controlled Trial Comparing the Occurrence of Major Adverse Cardiovascular Events MACEs in Patients With Prostate Cancer and Cardiovascular Disease Receiving Degarelix Gonadotropin-Releasing Hormone GnRH Receptor Antagonist or Leuprolide GnRH Receptor Agonist | $1.1M | 0 | 388 |
| An open-label, single-dose, randomized, 2-way cross-over study comparing pharmacokineticspharmacodynamics of 4 mg of ZOMACTONTM 5 mg powder and solvent for injection and 4 mg HUMATROPE 5 mg powder and solvent for injection administered subcutaneously in healthy adult subjects | $646,708 | 0 | 4 |
| A Randomized, Double-blind, Placebo-controlled, Phase 2 Trial Assessing Efficacy, Safety, Dose-response of Quinagolide Vaginal Rings Administered Sequentially for 8 Menstrual Cycles in Women With Moderate-Severe Endometriosis-related Pain | $573,165 | 0 | 127 |
| A Randomized, Double-Blind, Placebo-Controlled, Multicenter Study Investigating the Efficacy and Safety of Mesalamine 4 g Extended-Release Granules Sachet for the Induction of Clinical and Endoscopic Remission in Active, Mild to Moderate Ulcerative Colitis | $485,373 | 0 | 82 |
| A Randomized, Assessor-Blind, Parallel-Groups, Multicenter Trial Assessing the Safety and Efficacy, Including Pharmacokinetic Assessments, of CLENPIQ in Children Aged 2 Years to Less Than 9 Years | $359,491 | 0 | 40 |
| A Multi-Center, Randomized, Pivotal Study Evaluating AMPLEX Compared To Autogenous Bone Graft in Subjects Indicated for Arthrodesis Surgery Involving the Hindfoot or Ankle | $343,377 | 0 | 90 |
| A Multi-Center, Randomized, Assessor-Blind, Controlled Trial Comparing the Occurrence of Major Adverse Cardiovascular Events (MACEs) in Patients With Prostate Cancer and Cardiovascular Disease Receiving Degarelix (Gonadotropin-Releasing Hormone (GnRH) Receptor Antagonist) or Leuprolide (GnRH Receptor Agonist) | $321,233 | 0 | 68 |
| A Multi-Center, Randomized, Pivotal Study EvaluatingAMPLEXCompared To Autogenous Bone Graft in Subjects Indicated for Arthrodesis Surgery Involving the Hindfoot or Ankle | $298,388 | 0 | 102 |
| A Randomized, Double-Blind, Placebo-Controlled, Multicenter Study Investigating the Efficacy and Safety of Mesalamine 2 g Extended-Release Granules Sachet for Maintenance of Clinical and Endoscopic Remission in Ulcerative Colitis | $220,337 | 0 | 52 |
| A Multicenter, Double-Blind, Randomized, Placebo-Controlled Study Evaluating Three Doses of Subcutaneous Pulsatile GnRH Administered via OmniPod Pump for Ovulation Induction in Female Subjects with Primary Amenorrhea with Hypogonadotropic Hypogonadism | $208,469 | 0 | 28 |
| A Multi-Center, Randomized, Pivotal Study Evaluating?AMPLEX?Compared To Autogenous Bone Graft in Subjects Indicated for Arthrodesis Surgery Involving the Hindfoot or Ankle | $141,347 | 0 | 49 |
| A Randomized, Assessor-Blind, Multicenter, Dose-Ranging Study Comparing the Safety and Efficacy of Prepopik Versus Polyethylene Glycol Preparation Local Standard of Care in Children Aged 9 Years to 16 Years | $92,247 | 0 | 33 |
| Randomized Trial Assessing Quinagolide Vaginal Ring for Endometriosis-related Pain RAQUEL | $91,650 | 0 | 9 |
| A Double-blind, Randomised, Placebo-controlled, Phase 2b3 Adaptive Clinical Trial Investigating the Efficacy and Safety of Selepressin as Treatment for Patients with Vasopressor-dependent Septic Shock | $47,586 | 0 | 24 |
| A Randomized, Assessor-Blind, Multicenter, Dose-Ranging Study Comparing the Safety and Efficacy of Prepopik versus Polyethylene Glycol Preparation Local Standard of Care in Children Aged 9 Years to 16 years | $20,583 | 0 | 7 |
| A Randomized, Double-blind Double-dummy Trial Comparing MENOPUR Solution for Injection in a Pre-filled Pen and MENOPUR Powder and Solvent for Solution for Injection Menotropins for Injection in a GnRH Agonist Cycle in Women Aged 18-42 Years Undergoing an Assisted Reproductive Technology Program | $10,140 | 0 | 5 |
| A Multicenter, Double-Blind, Randomized, Placebo-Controlled Study Evaluating Two Doses of Subcutaneous Pulsatile GnRH Administered via OmniPod Pump for Ovulation Induction in Female Subjects with Primary Amenorrhea with Hypogonadotropic Hypogonadism | $9,054 | 0 | 1 |
| A Randomized, Double-blind, Placebo-controlled, Multicenter Trial Exploring the Efficacy and Safety of Intra-nasal Administration of Merotocin in Increasing Milk Production in Maternal Subjects With Preterm Delivery and Inadequate Milk Production | $8,192 | 0 | 1 |
| A Randomized, Double-Blind, Placebo-Controlled, Multi-center Trial Exploring the Efficacy and Safety of Intra-Nasal Administration of FE 202767 in Increasing Milk Production in Women with Preterm Delivery and Inadequate Milk Production | $6,587 | 0 | 1 |
| A Multi-Center, Randomized, Assessor-Blind, Controlled Trial Comparing the Occurrence of Major Adverse Cardiovascular Events MACEs in Patients with Prostate Cancer and Cardiovascular Disease Receiving Degarelix GnRH antagonist or Leuprolide LHRH agonist | $4,725 | 0 | 1 |
| A Randomised, Double-blind, Placebo-controlled, Multicentre Trial Exploring the Efficacy and Safety of Intra-nasal Administration of FE 202767 in Increasing Milk Production in Maternal Subjects With Preterm Delivery and Inadequate Milk Production | $2,513 | 0 | 1 |
| A Multi-Center, Randomized, Pivotal Study Evaluating?AMPLEX??Compared To Autogenous Bone Graft in Subjects Indicated for Arthrodesis Surgery Involving the Hindfoot or Ankle | $2,000 | 0 | 1 |
| Comparison of MENOPUR Liquid and Powder in Women Undergoing Assisted Reproductive Technology (ART) | $455.17 | 0 | 1 |
Payments by Medical Specialty
Top Paid Doctors
| Doctor | Specialty | Location | Total | 2021 |
|---|---|---|---|---|
| Nancy Lynch, M.d, M.D | Hand Surgery | San Mateo, CA | $737,845 | $0 |
| Benjamin Leader, M.d., Ph.d, M.D., PH.D | Emergency Medicine | Woburn, MA | $42,988 | $0 |
| Dr. Bernd Schnabl, M.d, M.D | Gastroenterology | San Diego, CA | $20,510 | $0 |
| Dr. Arun Sanyal, M.d, M.D | Internal Medicine | Richmond, VA | $19,232 | $0 |
| Dr. Osvaldo Padron, M.d, M.D | Specialist | Tampa, FL | $8,757 | $0 |
| Dr. Cigdem Tanrikut, Md, MD | Urology | Boston, MA | $7,530 | $0 |
| Dr. John Amatruda, M.d, M.D | Specialist | New York, NY | $7,450 | $0 |
| Dr. Paul Watkins, Md, MD | Gastroenterology | Chapel Hill, NC | $6,439 | $0 |
| George Saffouri, Md, MD | Internal Medicine | Redlands, CA | $4,950 | $0 |
| Reed Hogan, Md, MD | Gastroenterology | Flowood, MS | $4,750 | $0 |
| Steven Fochios, Md, MD | Gastroenterology | New York, NY | $4,400 | $0 |
| Sahil Khanna, Mbbs, MBBS | Internal Medicine | Rochester, MN | $3,871 | $0 |
| Paul Kwo, M.d, M.D | Gastroenterology | Stanford, CA | $3,644 | $0 |
| Dr. Judith Baumhauer, M.d, M.D | Orthopaedic Trauma | Rochester, NY | $3,420 | $0 |
| Dr. Harish Gagneja, Md, MD | Gastroenterology | Austin, TX | $3,000 | $0 |
| Tauseef Ali, M.d, M.D | Gastroenterology | Oklahoma City, OK | $3,000 | $0 |
| Rohit Singhania, M.d, M.D | Gastroenterology | Manchester, CT | $2,400 | $0 |
| Dr. Henry Mitcheson, Md, MD | Urology | Watertown, MA | $2,364 | $0 |
| Genevieve Neal-Perry, Md, Phd, MD, PHD | Reproductive Endocrinology | Raleigh, NC | $2,160 | $0 |
| Dr. Giuseppe Marzella, Md, MD | Pediatrics | East Hanover, NJ | $1,820 | $0 |
| Michael Dunn, M.d, M.D | Internal Medicine | Omaha, NE | $1,695 | $0 |
| Philip Brodak, Md, MD | Urology | Murrieta, CA | $1,692 | $0 |
| Dr. Beth Rackow, Md, MD | Reproductive Endocrinology | New York, NY | $1,680 | $0 |
| James Liu, Md, MD | Reproductive Endocrinology | Cleveland, OH | $1,593 | $0 |
| Roger Beyer, M.d, M.D | Urogynecology and Reconstructive Pelvic Surgery | Kalamazoo, MI | $1,483 | $0 |
About Ferring International Pharmascience Center US
Ferring International Pharmascience Center US has made $45.0M in payments to 127 healthcare providers, recorded across 3,734 transactions in the CMS Open Payments database. In 2024, the company paid $116,583. The top product by payment volume is MENOPUR ($9.1M).
Payments were distributed across 26 medical specialties. The top specialty by payment amount is Hand Surgery ($737,845 to 1 doctors).
Payment categories include: Food & Beverage ($10,651), Consulting ($856,063), Research ($44.1M), Travel & Lodging ($56,063).
Ferring International Pharmascience Center US is associated with 3 products in the CMS Open Payments database.